• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (285)
    • A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.
    • Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with "24-hr" analysis.
    • Gastroesophageal reflux disease in the Zollinger-Ellison syndrome.
    • Multiple good options are available for achalasia management.
    • The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age.
    • See All 285 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age.

The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017 04; 183:19-25.e2.

View in: PubMed

subject areas
  • Administration, Inhalation
  • Age Factors
  • Bronchopulmonary Dysplasia
  • Confidence Intervals
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Infant
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Male
  • Nitric Oxide
  • Pulmonary Surfactants
  • Respiration, Artificial
  • Respiratory Distress Syndrome, Newborn
  • Risk Assessment
  • Survival Rate
  • Time Factors

authors with profiles
  • Rita Marie Ryan
  • Frances Rowinsky Koch